Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Eric Jonasch, M D
CONTACT
Lead
M.D. Anderson Cancer Center
With
Primary Objectives * To demonstrate efficacy of combination tivozanib and nivolumab in advanced non-clear cell renal cell carcinoma (nccRCC). Secondary Objectives * To assess the safety and toxicity of combination tivozanib and nivolumab. * To estimate the duration of clinical efficacy Exploratory Objectives * To associate immune and tumor biomarkers with clinical efficacy
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted